PUBLISHER: GlobalData | PRODUCT CODE: 1410782
PUBLISHER: GlobalData | PRODUCT CODE: 1410782
Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Neurovascular Accessory Devices market for the year 2020 and beyond. Neurovascular accessories devices are used during neurovascular embolization and thrombectomy procedures to assist in the insertion of flow diversion stents, aneurysm clips and embolization coils etc. Accessories are comprised of Microcatheters, Micro guidewires and Support Catheters. Microguidewires are guidewires which are designed to navigate catheters into the neurological vasculature during neurovascular embolization and thrombectomy procedures.
Microcatheters are used during neurovascular procedures for the deployment of devices such as stent retrievers, embolization coils and liquid embolics etc. Support catheters are the neurovascular accessory device which is used to reinforce the walls of the vessel during neurovascular embolization and thrombectomy procedures. The neurovascular accessory devices market will generally follow epidemiological trends for neurovascular embolization and thrombectomy devices.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Neurovascular Accessory Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Stryker Corp, Medtronic Plc, Penumbra Inc, MicroVention Inc, Asahi Intecc Co Ltd, Cerenovus, Balt SAS, Acandis GmbH & Co KG, Phenox GmbH, PLS Minimally Invasive Interventional Medical Co., Ltd and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable